HCW Biologics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $15 | $6 | $5 | $394 |
Gross Profit | -170 | 1 | 1 | 78 |
EBITDA | -4,253 | -1,304 | -1,248 | -1,915 |
EBIT | -4,427 | -1,596 | -1,667 | -2,597 |
Net Income | -4,554 | -1,927 | -2,196 | -3,373 |
Net Change In Cash | 15 | 6 | 5 | 394 |
Free Cash Flow | -3,239 | -3,282 | -3,513 | -2,948 |
Cash | 1,096 | 2,438 | 1,107 | 4,674 |
Basic Shares | 2,260 | 1,780 | 44,675 | 38,793 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,566 | $2,841 | $6,722 | $4,099 |
Gross Profit | 959 | 560 | 2,586 | -543 |
EBITDA | -27,680 | -23,576 | -14,056 | -12,318 |
EBIT | -28,865 | -24,711 | -14,774 | -12,862 |
Net Income | -30,023 | -24,994 | -14,900 | -12,862 |
Net Change In Cash | 2,566 | 2,841 | 6,722 | 4,099 |
Cost of Revenue | 10,595 | |||
Free Cash Flow | -14,489 | -28,716 | -20,661 | -11,022 |
Cash | 4,674 | 3,595 | 22,326 | 11,730 |
Basic Shares | 38,793 | 35,929 | 35,822 | 35,768 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$2.02 |
2025-06-30 | -$6.79 |
2025-03-31 | -$1.97 |
2024-12-31 | -$3.20 |
